Future Health Care Equity ETF (GDOC)
NYSEARCA: GDOC · Real-Time Price · USD
31.46
-0.19 (-0.59%)
Apr 30, 2025, 11:00 AM EDT - Market open
| Assets | $19.69M |
| Expense Ratio | 0.75% |
| PE Ratio | 34.05 |
| Shares Out | 625,000 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.02% |
| Ex-Dividend Date | Dec 23, 2024 |
| Payout Ratio | 0.60% |
| 1-Year Return | -4.31% |
| Volume | 1,814 |
| Open | 31.47 |
| Previous Close | 31.65 |
| Day's Range | 31.46 - 31.47 |
| 52-Week Low | 28.34 |
| 52-Week High | 37.23 |
| Beta | 0.88 |
| Holdings | 43 |
| Inception Date | Nov 9, 2021 |
About GDOC
Fund Home PageThe Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is issued by Goldman Sachs.
Asset Class Equity
Category Health
Stock Exchange NYSEARCA
Ticker Symbol GDOC
ETF Provider Goldman Sachs
Top 10 Holdings
57.91% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.50% |
| Boston Scientific Corporation | BSX | 8.40% |
| UnitedHealth Group Incorporated | UNH | 6.20% |
| AbbVie Inc. | ABBV | 6.07% |
| Abbott Laboratories | ABT | 5.30% |
| Intuitive Surgical, Inc. | ISRG | 5.15% |
| The Cooper Companies, Inc. | COO | 4.28% |
| Insulet Corporation | PODD | 4.13% |
| AstraZeneca PLC | AZN | 4.08% |
| Merck & Co., Inc. | MRK | 3.80% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2024 | $0.00576 | Dec 30, 2024 |
| Dec 26, 2023 | $0.17894 | Jan 2, 2024 |
News
Goldman Sachs is building on the disruptive investing theme with a trio of new ETFs
Goldman Sachs Group is offering investors new ways to seek equity gains from disruptive companies, with its asset management business launching three exchange-traded funds focused on secular growth tr...
3 years ago - Market Watch